Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
Molecular Cancer Therapeutics|February 10, 2012
CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activityJoyce James, Bruce Ruggeri, Robert C Armstrong, et al.
ESMO Open|August 27, 2022
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort AD V T Catenacci, Y-K Kang, H H Yoon, et al.
Journal of Emergency Nursing|July 14, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Scientific Reports|May 31, 2018
Single-shot 3D coherent diffractive imaging of core-shell nanoparticles with elemental specificityAlan Pryor, Arjun Rana, Rui Xu, et al.
The Journal of Emergency Medicine|July 17, 2010
The future of emergency medicineSandra M Schneider, Angela F Gardner, Larry D Weiss, et al.
Journal of Medicinal Chemistry|December 16, 2011
Identification of 1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride (CEP-32496), a highly potent and orally efficacious inhibitor of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF) V600EMartin W Rowbottom, Raffaella Faraoni, Qi Chao, et al.
Nature Ecology & Evolution|January 21, 2025
Insights from a century of data reveal global trends in ex situ living plant collectionsÁngela Cano, Jake Powell, Anthony S Aiello, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 21, 2021
Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotoniaAlison M Muir, Jennifer F Gardner, Richard H van Jaarsveld, et al.
Pageof 34